edited by: Namit Singh Sengar
Last Update: February 20, 2023, 14:00 IST
The shares of the company are expected to be listed on BSE SME on March 6, 2023
The group of companies mainly operates in and around the pharmaceutical and chemical sector.
Patreon Exim Limited plans to go public with an Initial Public Offering (IPO) from February 21 to February 24, 2023.
The company, which started as a partnership firm in 1982 and later became a private limited company, will be listed on the BSE.
The shares of the company are expected to be listed on BSE SME on March 6, 2023. The company received an approval letter from BSE on January 25 to use its name in this offer document for listing of shares on SME platform of BSE.
according to a report by monocontrolPatron Exim is a part of a group of companies which includes Sedac Medicorp, Evok Remedies, Earum Pharmaceuticals, Oxilia Pharmaceuticals, Madrid Diamonds, Atlantis Exim, NG Overseas and many more.
The group of companies mainly operates in and around the pharmaceutical and chemical sector.
The fixed price issue will launch at a price of Rs 27 per share with an issue size of Rs 16.69 crore. The proceeds of the Public Offer will be used to meet working capital requirements, general corporate objectives and public issue expenses.
IPO Based on the face value of Rs 10 and NAV of Rs 17, the equity share price has been kept at Rs 27.
Patron Exim procures, manufactures and supplies surgical, non-surgical goods, active pharmaceutical ingredients, drug intermediates, medical pharmaceutical chemicals, bio-chemical formulations and formulations and other products to the overseas and domestic markets.
The company has a diverse product portfolio, experienced promoters and high level of customer satisfaction apart from 20 years of business expertise and a vast array of certifications to do business smoothly in the international markets.
read all latest business news Here